(NASDAQ: FTRE) Fortrea Holdings's forecast annual revenue growth rate of -0.72% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Fortrea Holdings's revenue in 2025 is $2,685,600,000.On average, 5 Wall Street analysts forecast FTRE's revenue for 2025 to be $225,293,670,000, with the lowest FTRE revenue forecast at $224,163,630,000, and the highest FTRE revenue forecast at $226,251,000,000. On average, 5 Wall Street analysts forecast FTRE's revenue for 2026 to be $228,114,720,000, with the lowest FTRE revenue forecast at $226,560,600,000, and the highest FTRE revenue forecast at $229,707,000,000.
In 2027, FTRE is forecast to generate $238,425,390,000 in revenue, with the lowest revenue forecast at $236,302,560,000 and the highest revenue forecast at $242,334,000,000.